An International Observational Study of Outpatients with SARS-CoV-2 Infection
How does COVID-19 progress in adults that test positive for the virus but that don't need to be immediately admitted to hospital?
What is this study about?
SARS-CoV-2 is a coronavirus that emerged in China in late 2019 causing a novel Corona-Virus Induced Disease (COVID-19). COVID-19 is spreading rapidly throughout the world. While a proportion of people with COVID-19 have sufficiently severe symptoms to require hospitalization at the time of initial symptom onset, in others the disease may remain mild, and in some cases there has been observed a worsening of symptoms a few days after initial presentation with relatively mild symptoms. There is an urgent need for understanding the progression of disease for individuals with SARS-CoV-2 infection/COVID-19 who do not require immediate hospitalization. The general aim of this study is therefore to estimate the rate of disease progression for adults who seek testing and test positive for SARS-CoV-2.
Type of study
Who is funding the study?
National Institute of Allergy and Infections, USA (NIAID)
When is it taking place?
May 2020 - Jan 2022
Where is it taking place?
This is an international study taking place in a number of countries including the USA, Argentina, Australia, Brazil, Indonesia, Mexico, Singapore, South Africa, Peru, Europe and the UK.
Who is included?
To be eligible for enrolment participants must be ≥ 18 years of age, not be hospitalised (outpatients), and have a signed informed consent. Participants with SARS-CoV-2 infection will be followed for 28 days.